High affinity humanized anti-TAG-72 monoclonalantibodies
US6348581B1 · kind B1 · utility
13Cited by
12References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 1998 |
| Grant date | Feb 19, 2002 |
| Priority date | — |
| Expiry date | Feb 18, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Novel humanized monoclonal antibodies, humanized antibody fragments, and derivatives thereof which specifically bind TAG-72 are provided as well as methods for their manufacture. These humanized antibodies are useful in the treatment of cancers which express TAG-72 as well as for diagnostic purposes, e.g., for in vivo imaging of tumors or cancer cells which express TAG-72.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.